In-vivo angiogenesis and progestogens

Human Reproduction

Volumn 17, Issue 3, 2002, Pages 786-793

  Hague, S ^a,b   MacKenzie, I Z ^a   Bicknell, R ^b   Rees, M C P ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Endometrium; Endothelial proliferation; Progestogens; Vascular density

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ADRENOMEDULLIN; BASIC FIBROBLAST GROWTH FACTOR; ESTROGEN; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NOMEGESTROL ACETATE; NORETHISTERONE; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAKTHROUGH BLEEDING; CONTRACEPTION; CONTROLLED STUDY; DISEASE CONTROL; DOSE RESPONSE; ENDOMETRIUM HYPERPLASIA; IN VIVO STUDY; INTRAUTERINE CONTRACEPTIVE DEVICE; LONG TERM EXPOSURE; MOUSE; NONHUMAN; PREMENOPAUSE; PROTEIN EXPRESSION; TISSUE GROWTH; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALIA;

EID: 0036121478     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.3.786     Document Type: Article

References (42)

1. An animal model to study menstrual bleeding
2. The localization of androgen receptors in human bone
3. Quantitative in-vivo studies on angiogenesis in a rat sponge model
4. Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate. Endometrium Study Group
5. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium
6. Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle
7. Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium
8. Levonorgestrel-releasing contraceptive implant
9. Management of vaginal bleeding irregularities induced by progestin-only contraceptives
10. Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis
11. Human endometrial angiogenesis
12. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel
13. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density
14. Optimizing continuous-combined hormone replacement therapy for postmenopausal women: A comparison of six different treatment regimens
15. Endometrial vasculature in Norplant users: Preliminary results from a hysteroscopic study
16. A longitudinal study of changes in endometrial microvascular density in Norplant implant users
17. Endometrial haemostasis
18. Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis. Further studies with angiogenic modifiers
19. Expression of sex steroid receptors and Ki-67 in the endometria of menorrhagic women: Effects of intrauterine levonorgestrel
20. Medical management of dysfunctional uterine bleeding
21. Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery
22. Screening of anti-progestagens by receptor studies and bioassays
23. The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium
24. Presence of estrogen receptor beta in the human endometrium through the cycle: Expression in glandular, stromal, and vascular cells
25. Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models
26. A comparison of flurbiprofen, tranexamic acid and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia
27. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD
28. The effects of natural and synthetic sex steroids on human decidual endothelial cell proliferation
29. Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices
30. Immunohistochemical localization of estradiol and progesterone receptors in human uterus throughout pregnancy: Expression in endometrial blood vessels
31. The endometrium and hormone replacement therapy: Safety and bleeding
32. Intrauterine application of progestins in hormone replacement therapy: A review
33. Endothelial cell dysfunction following prolonged activation of progesterone receptor
34. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel
35. The effect of high dose medium and long-term progestogen exposure on endometrial vessels
36. Effect of different cyclical sequential progestins on endometrial vascularity in postmenopausal women compared with the natural cycle: A morphometric analysis
37. Immunohistochemical localization of progesterone receptor in human decidua of early pregnancy
38. Female genital tract
39. Inhibition of angiogenesis with combination treatments of angiogstatic steroids and suramin
40. Angiostatic activities of medroxyprogesterone acetate and its analogues
41. Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: Expression of VEGF in the human endometrium
42. PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium